These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11264453)

  • 61. Impact of genetic polymorphisms of drug transporters
    Madejczyk AM; Canzian F; Góra-Tybor J; Campa D; Sacha T; Link-Lenczowska D; Florek I; Prejzner W; Całbecka M; Rymko M; Dudziński M; Orzechowska MJ; Jamroziak K
    Front Oncol; 2022; 12():952640. PubMed ID: 36212403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.
    Tufail M; Cui J; Wu C
    Am J Cancer Res; 2022; 12(7):2920-2949. PubMed ID: 35968356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity.
    Petros Z; Habtewold A; Makonnen E; Aklillu E
    Sci Rep; 2022 Jun; 12(1):9698. PubMed ID: 35690682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Challenge and Importance of Integrating Drug-Nutrient-Genome Interactions in Personalized Cardiovascular Healthcare.
    Stouras I; Papaioannou TG; Tsioufis K; Eliopoulos AG; Sanoudou D
    J Pers Med; 2022 Mar; 12(4):. PubMed ID: 35455629
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular Mechanisms of the SLC13A5 Gene Transcription.
    Li Z; Wang H
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Arsenic: Various species with different effects on cytochrome P450 regulation in humans.
    El-Ghiaty MA; El-Kadi AOS
    EXCLI J; 2021; 20():1184-1242. PubMed ID: 34512225
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PharmVar GeneFocus: CYP2B6.
    Desta Z; El-Boraie A; Gong L; Somogyi AA; Lauschke VM; Dandara C; Klein K; Miller NA; Klein TE; Tyndale RF; Whirl-Carrillo M; Gaedigk A
    Clin Pharmacol Ther; 2021 Jul; 110(1):82-97. PubMed ID: 33448339
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of human pregnane X receptor activators identified from a screening of the Tox21 compound library.
    Lynch C; Sakamuru S; Huang R; Niebler J; Ferguson SS; Xia M
    Biochem Pharmacol; 2021 Feb; 184():114368. PubMed ID: 33333074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potential benefits of patchouli alcohol in prevention of human diseases: A mechanistic review.
    Lee HS; Lee J; Smolensky D; Lee SH
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107056. PubMed ID: 33039955
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.
    Ooeda K; Kubiura-Ichimaru M; Tsuji S; Okuyama S; Yamashita M; Mine A; Kawamura F; Ueyama T; Tada M
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00652. PubMed ID: 32955797
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Noncanonical Constitutive Androstane Receptor Signaling in Gene Regulation.
    Pustylnyak YA; Gulyaeva LF; Pustylnyak VO
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937916
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.
    Mackowiak B; Hodge J; Stern S; Wang H
    Drug Metab Dispos; 2018 Sep; 46(9):1361-1371. PubMed ID: 29759961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A current structural perspective on PXR and CAR in drug metabolism.
    Buchman CD; Chai SC; Chen T
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):635-647. PubMed ID: 29757018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CINPA1 binds directly to constitutive androstane receptor and inhibits its activity.
    Cherian MT; Chai SC; Wright WC; Singh A; Alexandra Casal M; Zheng J; Wu J; Lee RE; Griffin PR; Chen T
    Biochem Pharmacol; 2018 Jun; 152():211-223. PubMed ID: 29608908
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Allosteric pathways in nuclear receptors - Potential targets for drug design.
    Fernandez EJ
    Pharmacol Ther; 2018 Mar; 183():152-159. PubMed ID: 29080700
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.
    Cornelison R; Llaneza DC; Landen CN
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29057791
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7.
    Ueyama T; Tsuji S; Sugiyama T; Tada M
    Sci Rep; 2017 Jun; 7(1):2874. PubMed ID: 28588200
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A brief history of the discovery of PXR and CAR as xenobiotic receptors.
    Yan J; Xie W
    Acta Pharm Sin B; 2016 Sep; 6(5):450-452. PubMed ID: 27709013
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insights into CYP2B6-mediated drug-drug interactions.
    Hedrich WD; Hassan HE; Wang H
    Acta Pharm Sin B; 2016 Sep; 6(5):413-425. PubMed ID: 27709010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
    Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
    AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.